Formulation and Development of Ophthalmic Solution: Formulation and Development of Ophthalmic Solution for Non-steroidal Anti-inflammatory Drug (NSAID) - Couverture souple

Bhople, Amit; Sheaikh, Sameer; Patange, Harish

 
9783659268236: Formulation and Development of Ophthalmic Solution: Formulation and Development of Ophthalmic Solution for Non-steroidal Anti-inflammatory Drug (NSAID)
Couverture souple
ISBN 10 : 3659268232 ISBN 13 : 9783659268236
Editeur : LAP LAMBERT Academic Publishing, 2012

Synopsis

Ketorolac tromethmaine is a Nonsteroidal anti-inflammatory drug. It is used as Antipyretic, anti-inflammatory and analgesic. It is indicated Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis & for the treatment of postoperative inflammation. Preservative in high concentration hazardous to Ocular cell. Therefore, the aim of the present study was to formulate a formulation for ketorolac tromethmine (0.5%) ophthalmic solution using different concentration of Benzalkonium chloride as preservative. While reducing the concentration of Benzalkonium chloride it must be keep in mind that added quantity of preservative must meet compendial requirement of Preservative Efficacy Testing as per United state Pharmacopoeia (USP).The present research work is also planned to provide the data about the selection of suitable primary packaging material for Ketorolac tromethmine (0.5%) to achieve the better stability during the shelf life of the product.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Ketorolac tromethmaine is a Nonsteroidal anti-inflammatory drug. It is used as Antipyretic, anti-inflammatory and analgesic. It is indicated Ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis & for the treatment of postoperative inflammation. Preservative in high concentration hazardous to Ocular cell. Therefore, the aim of the present study was to formulate a formulation for ketorolac tromethmine (0.5%) ophthalmic solution using different concentration of Benzalkonium chloride as preservative. While reducing the concentration of Benzalkonium chloride it must be keep in mind that added quantity of preservative must meet compendial requirement of Preservative Efficacy Testing as per United state Pharmacopoeia (USP).The present research work is also planned to provide the data about the selection of suitable primary packaging material for Ketorolac tromethmine (0.5%) to achieve the better stability during the shelf life of the product.

Biographie de l'auteur

Mr. Amit Bhople has obtained his post graduation i.e. M.Pharm with specialization in Pharmaceutics. His main area of research is Novel Drug Delivery System and Osmotically controlled drug delivery system. He published number of research of research papers in various journals of national and international repute.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2012
Langue
anglais
ISBN 10 
3659268232
ISBN 13 
9783659268236
Reliure
Broché
Nombre de pages
128
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne